synthesi
inact
enzym
precursor
also
known
zymogen
serv
mechan
regul
execut
select
catalyt
activ
desir
time
andor
site
zymogen
usual
activ
proteolyt
cleavag
mani
virus
encod
proteas
execut
key
proteolyt
step
viral
life
cycl
describ
proof
concept
therapeut
approach
fight
viral
infect
erad
viral
infect
cell
exclus
thu
limit
viru
product
spread
use
hepat
c
viru
hcv
model
design
two
hcv
proteaseactiv
zymogen
chimer
toxin
denot
zymoxin
recombin
construct
bacteri
plant
toxin
diphtheria
toxin
dta
ricin
chain
rta
respect
fuse
ration
design
inhibitor
peptid
domain
via
hcv
proteasecleav
linker
toxin
fuse
bind
transloc
domain
pseudomona
exotoxin
order
enabl
transloc
mammalian
cell
cytoplasm
show
toxin
exhibit
cleavag
depend
increas
enzymat
activ
upon
proteas
cleavag
vitro
moreov
higher
level
cytotox
observ
zymoxin
appli
express
cell
hcv
infect
cell
demonstr
potenti
therapeut
window
increas
toxin
activ
correl
proteas
activ
treat
cell
thu
therapeut
window
larger
cell
express
recombin
hcv
infect
cell
suggest
zymoxin
approach
may
appropri
applic
lifethreaten
acut
infect
much
higher
level
activ
proteas
would
expect
citat
shapira
galtanami
nahari
l
litvakgreenfeld
zemel
r
et
al
engin
toxin
zymoxin
activ
hcv
proteas
remov
inhibitori
protein
domain
plo
one
term
zymogen
refer
inact
enzym
precursor
convert
activ
form
follow
biochem
modif
usual
proteolyt
process
among
known
import
group
enzym
activ
way
cystein
aspart
acid
proteas
caspas
play
essenti
role
variou
stage
apoptot
process
secret
digest
enzym
like
pepsin
trypsin
blood
coagul
factor
previous
alexand
varshavski
suggest
construct
new
kind
toxin
refer
sitoxin
concept
artifici
combin
sever
function
protein
domain
produc
therapeut
effect
molecul
specif
sitoxin
compris
effector
domain
domain
bear
intracellular
signal
moieti
polypeptid
sequenc
locat
effector
domain
domain
bear
intracellular
signal
moieti
specifi
cleavag
site
predetermin
proteas
follow
introduct
sitoxin
target
cell
express
specif
proteas
cleavag
proteas
separ
effector
domain
sitoxin
intracellular
signal
moieti
result
either
longerliv
therefor
toxic
effector
domain
effector
domain
move
cellular
compart
domain
nontox
cellular
compart
domain
abl
exert
toxic
effect
strategi
previous
appli
faln
et
al
describ
construct
diphtheria
toxin
base
sitoxin
contain
signal
nendrulemedi
degrad
upstream
cleavag
site
proteas
hiv
type
invitro
cleavag
viral
proteas
substanti
increas
abil
toxin
inhibit
cellular
protein
synthesi
howev
toxin
unabl
select
erad
cell
appar
due
low
cytosol
proteas
activ
pseudomona
exotoxin
pe
threedomain
bacteri
toxin
kill
mammalian
cell
gain
entri
cytosol
inactiv
protein
synthesi
pe
compos
major
domain
minor
domain
domain
aa
cellbind
domain
domain
transloc
domain
enabl
pe
reach
cytosol
domain
adpribosyl
domain
inactiv
elong
factor
caus
cell
death
pathway
toxin
entri
includ
bind
surfac
receptor
pe
bind
enter
mammalian
cell
via
bind
domain
alpha
receptorlow
densiti
lipoprotein
receptorrel
protein
lrp
ubiquit
express
tissu
cell
type
intern
via
coat
pit
endosom
proteolyt
cleavag
within
domain
reduct
disulfid
bond
proteolyt
cleavag
mediat
cellular
proteas
furin
gener
activ
ctermin
fragment
residu
final
enzymat
activ
ctermin
fragment
transloc
retrograd
transport
golgi
apparatu
endoplasm
reticulum
cytosol
cytosol
fragment
inhibit
protein
synthesi
adp
ribosyl
elong
factor
diphtheria
toxin
dt
produc
corynebacterium
diphtheria
kill
mammalian
cell
mechan
similar
pe
name
gain
entri
cytosol
inactiv
protein
synthesi
adp
ribosyl
elong
factor
diphtheria
toxin
compos
three
structur
function
domain
amino
termin
catalyt
c
domain
also
refer
dta
transloc
domain
carboxytermin
receptor
bind
r
domain
dt
cleav
surfac
sensit
eukaryot
cell
enzym
furin
follow
receptor
heparin
bind
epiderm
growth
factorlik
precursor
bind
dichain
protein
link
singl
disulfid
bond
intern
clathrin
coat
pit
reach
lumen
develop
endosom
upon
acidif
domain
facilit
transloc
catalyt
domain
directli
across
endosom
membran
host
cell
cytoplasm
ricinu
communi
ricin
toxin
ribosomeinactiv
protein
rip
irrevers
damag
ribosom
remov
singl
adenin
residu
depurin
gaga
sequenc
univers
conserv
loop
top
stem
rrna
socal
sarcinricin
loop
srl
toxin
consist
two
chain
link
togeth
disulfid
bond
one
chain
approxim
kda
nglycosidas
enzymat
activ
chain
one
approxim
kda
lectin
properti
bind
carbohydr
ligand
target
cell
surfac
b
chain
cellbound
ricin
taken
endocytosi
toxin
molecul
recycl
back
cell
surfac
transport
lysosom
degrad
small
fraction
eventu
transloc
retrograd
transport
transgolgi
network
backward
golgi
apparatu
endoplasm
reticulum
cytosol
hcv
small
envelop
rna
viru
belong
hepaciviru
genu
flavivirida
famili
recogn
major
caus
chronic
liver
diseas
affect
approxim
million
peopl
worldwid
present
time
persist
infect
associ
develop
chronic
hepat
hepat
steatosi
cirrhosi
hepatocellular
carcinoma
protect
vaccin
hcv
yet
avail
even
recent
combin
pegyl
ainterferon
ribavirin
fail
elimin
infect
nearli
infect
hcv
genom
encod
one
larg
open
read
frame
translat
polyprotein
proteolyt
process
yield
viral
structur
nonstructur
ns
protein
envelop
glycoprotein
well
core
protein
structur
protein
form
viral
particl
nonstructur
protein
includ
ion
channel
proteas
serin
proteaserna
helicas
cofactor
protein
rnadepend
rna
polymeras
rdrp
two
viral
encod
proteas
particip
polyprotein
process
autoproteas
cleav
ci
junction
serin
proteas
also
commonli
refer
proteas
cleav
four
downstream
ns
protein
junction
extens
studi
hcv
protein
possess
multipl
enzymat
activ
essenti
hcv
replic
nterminu
complex
cofactor
primarili
function
serin
proteas
cleav
viral
polyprotein
precursor
downstream
remain
protein
helicas
ntpase
activ
essenti
hcv
replic
long
time
approach
studi
full
hcv
life
cycl
experiment
infect
chimpanze
observ
infect
patient
comparison
virus
member
flavivirida
famili
recent
differ
system
enabl
replic
growth
hcv
cell
cultur
hcvcc
develop
advanc
result
establish
current
use
model
studi
hepat
c
viru
recombin
infecti
hcv
particl
genotyp
strain
chimer
virus
gener
background
could
produc
hepatomaderiv
cell
line
permiss
hcv
replic
hcvcc
system
render
step
hcv
life
cycl
includ
entri
releas
viral
particl
amen
systemat
analysi
purpos
develop
proof
concept
potenti
new
antivir
agent
specif
erad
viral
infect
cell
thu
limit
viru
product
spread
design
two
chimer
toxin
activ
mediat
proteas
cleavag
chimer
toxin
base
fusion
bind
transloc
domain
pseudomona
exotoxin
serv
vehicl
transloc
cytoplasm
target
cell
modifi
catalyt
domain
bacteri
plant
toxin
diphtheria
toxin
dta
ricin
toxin
rta
respect
construct
denot
zymoxin
zymogen
toxin
ration
design
inhibitori
peptidedomain
fuse
c
terminu
constitut
activ
toxin
inhibitori
domain
preced
junction
sequenc
cleavag
viral
proteas
liber
toxin
inhibitori
moieti
toxin
exhibit
consider
level
proteasedepend
activ
detect
invitro
enzymat
assay
well
appli
express
model
cell
express
cytosol
membran
bound
test
hcv
infect
cell
less
dramat
still
signific
enhanc
cytotox
observ
suggest
erad
viral
proteas
express
cell
specif
rang
toxin
concentr
achiev
purpos
establish
model
cell
line
express
hcv
proteas
construct
fusion
protein
previous
describ
also
known
singlechain
singl
chain
construct
short
synthet
peptid
encompass
residu
hcv
genotyp
link
n
terminu
proteas
domain
enhanc
green
fluoresc
protein
egfp
format
chosen
base
previou
unpublish
find
express
level
mammalian
cell
greatli
enhanc
upon
fusion
efficientlyexpress
protein
egfp
n
terminu
addit
anoth
construct
made
compris
fusion
egfp
full
length
proteaserna
helicas
follow
full
length
hcv
genotyp
oppos
predict
predominantli
cytoplasm
nucleocytoplasm
protein
rel
low
affin
membran
egfpful
length
strongli
interact
full
length
follow
autocleavag
expect
associ
intracellular
membran
express
mammalian
cell
precis
mimick
intracellular
local
complex
hcv
infect
cell
reason
hydrophob
amino
termin
domain
direct
complex
er
membran
erlik
modifi
compart
sinc
sign
cell
toxic
observ
follow
prolong
constitut
express
egfpful
cell
teton
induc
system
express
establish
system
base
trex
tm
cell
line
invitrogen
express
egfp
full
also
later
refer
full
respect
induc
addit
tetracyclin
tet
growth
medium
order
monitor
specif
proteolyt
activ
tet
induc
cell
construct
substrateencod
plasmid
encod
modif
previous
describ
polypeptid
serv
substrat
proteolysi
proteas
plasmid
denot
encod
fusion
maltos
bind
protein
mbp
enhanc
green
fluoresc
protein
egfp
amino
acid
minim
cleavag
sequenc
hcv
site
deriv
hcv
genotyp
genotyp
sequenc
ident
cellulos
bind
domain
cbd
shown
fig
addit
tet
select
stabl
clone
induc
system
result
egfpful
express
assay
fluoresc
confoc
microscopi
fig
respect
immunoblot
fig
lower
panel
regard
intracellular
local
proteas
egfpful
partial
coloc
calnexin
er
cell
appar
absent
nucleu
less
diffus
distribut
pattern
comparison
nucleocytoplam
expect
strong
coloc
howev
observ
egfpful
chimer
fluoresc
protein
fuse
ctermin
er
membran
anchor
tyrosin
phosphatas
data
shown
immunoblot
analysi
also
show
effici
cleavag
refer
cleavabl
substrat
fig
cell
transfect
pcmvmbpegfp
immunofluoresc
analysi
induc
express
cell
cell
induc
express
egfpful
seed
coverslip
wellplat
hour
cell
treat
tetracyclin
hour
fix
permeabil
follow
immunostain
rabbit
anticalnexin
goat
anti
rabbit
er
visual
red
nuclei
stain
hoechst
blue
slide
examin
confoc
fluoresc
microscopi
uninduc
cell
b
induc
express
cell
c
induc
full
express
cell
lower
panel
invivo
substrat
cleavag
cell
induc
express
transfect
plasmid
cleavabl
substrat
see
scheme
hour
cell
treat
tetracyclin
left
untreat
hour
later
cell
lyse
protein
total
cell
extract
analyz
immunoblot
rabbit
antiegfp
antibodi
detect
mouseserum
antimbp
sensit
antiegfp
detect
cleavag
product
substrat
follow
hrpconjug
secondari
antibodi
ecl
develop
e
band
correspond
full
length
substrat
cleav
substrat
indic
arrow
similar
result
obtain
also
cell
induc
express
egfpful
induc
express
fig
faint
band
correspond
cleavag
product
also
detect
sampl
uninduc
cell
probabl
due
degre
leaki
tet
induc
system
allow
low
basal
transcript
proteas
absenc
extern
ad
tet
support
assumpt
singl
band
correspond
full
length
substrat
detect
trex
cell
transfect
substrat
encod
vector
data
shown
infer
toxinsubstr
interact
model
previous
present
jorgensen
colleagu
intim
interact
dta
intracellular
target
elong
factor
predict
resid
c
termin
portion
toxin
consid
predict
assum
fusion
bulki
polypeptid
moieti
c
terminu
dta
may
hinder
toxinsubstr
interact
furthermor
human
alphadefensin
found
neutral
toxin
monoadpribosyltransferas
famili
dta
belong
construct
zymoxin
catalyt
domain
dta
inhibit
inhibit
reliev
cleavag
chose
fuse
c
terminu
dta
preced
amino
acid
minim
cleavag
sequenc
hcv
genotyp
site
refer
cleavag
site
flexibl
linker
amino
acid
rich
serin
glycin
residu
allow
domain
fold
back
interact
interact
site
dta
construct
fuse
n
terminu
bind
transloc
domain
pseudomona
exotoxin
pe
order
enabl
intern
traffick
cytosol
mammalian
cell
demonstr
previous
guidirontani
natur
bind
transloc
domain
diphtheria
toxin
posit
c
terminu
wt
toxin
substitut
polypeptid
addit
tag
follow
kdel
er
retriev
signal
place
c
termin
portion
construct
pedtacleavag
sitedefensin
facilit
toxin
purif
kdel
retriev
system
exploit
pe
order
reach
er
lumen
respect
extens
posit
c
terminu
follow
chimer
construct
express
e
coli
cell
purifi
periplasm
fraction
describ
materi
method
control
uncleav
chimer
toxin
construct
cleavag
site
mutat
substitut
cystein
arginin
tyrosin
alanin
pedtamut
cleavag
sitedefensin
see
scheme
fig
protein
sequenc
zymoxin
describ
well
zymoxin
use
studi
describ
later
found
support
text
enzymat
activ
dtabas
zymoxin
elev
follow
proteas
cleavag
order
evalu
suscept
construct
cleavag
proteas
evalu
influenc
cleavag
adpribosyl
activ
invitro
cleavag
reaction
carri
incub
chimer
toxin
recombin
fusion
produc
e
coli
follow
adpribosyl
activ
assay
use
wheat
germ
extract
sourc
elong
factor
schemat
represent
pedta
chimer
toxin
invitro
cleavag
product
adpribosyl
assay
result
shown
fig
shown
incub
toxin
pedtacleavag
sitedefensin
recombin
proteas
result
complet
cleavag
chimer
toxin
appear
lower
weight
product
immunoblot
assay
use
antip
antibodi
fig
right
upper
panel
moreov
cleavag
led
consider
increas
adpribosyl
activ
toxin
fig
contrast
toxin
mutat
cleavag
site
resist
cleavag
signific
increas
adpribosyl
activ
could
detect
incub
proteas
interestingli
adpribosyl
activ
uncleav
toxin
higher
basal
activ
uncleavedcleav
toxin
lower
cleav
toxin
howev
emphas
point
enzymat
activ
cytotox
may
affect
multipl
factor
transloc
effici
thermodynam
stabil
intracellular
halflif
interact
substrat
might
influenc
even
slight
chang
primari
sequenc
toxin
basic
correct
control
cleavabl
toxin
uncleav
cytotox
dtabas
zymoxin
elev
express
cell
order
evalu
toxin
activ
hcv
proteas
invivo
model
cell
line
induc
uninduc
express
treat
pedtacleavag
sitedefensin
pedtamut
cleavag
sitedefensin
shown
fig
tetracyclin
induct
express
full
led
consider
activ
cleavabl
toxin
present
minor
cytotox
effect
uninduc
cell
contrari
enhanc
cytotox
activ
uncleav
toxin
evid
indic
induct
express
caus
gener
sensit
dta
base
toxin
cell
agreement
invitro
adpribosyl
assay
result
uncleav
toxin
basal
activ
potent
basal
activ
noncleav
cleavabl
toxin
uninduc
cell
treat
pedtacleavag
sitedefensin
context
worth
mention
anoth
uncleav
toxin
pedtano
cleavag
sitedefensin
whole
cleavag
site
delet
also
indiffer
presenc
proteas
potent
noncleav
cleavabl
toxin
present
minor
cytotox
effect
induc
uninduc
express
cell
data
shown
observ
suggest
correct
evalu
therapeut
window
zymoxin
may
offer
compar
cleav
uncleav
zymoxin
sinc
enzymat
activ
ricin
base
interact
ribosom
one
assum
interrupt
interact
probabl
reduc
toxic
recent
year
sever
group
investig
natur
interact
found
conserv
c
terminu
ribosom
stalk
protein
interact
ricin
shigalik
toxin
anoth
type
ii
ribosomeinactiv
protein
interact
requir
effici
ribosom
bind
cytotox
moreov
synthet
peptid
correspond
sequenc
conserv
c
terminu
shown
inhibit
ribosomeinactiv
function
later
crystal
structur
similar
peptid
complex
trichosanthin
tc
type
ribosomeinactiv
protein
rip
present
base
studi
clone
code
sequenc
catalyt
chain
ricin
rta
origin
ricinu
communi
genom
dna
prepar
bacteri
express
plasmid
next
construct
chimer
toxin
two
repeat
acid
residu
peptid
correspond
conserv
c
terminu
ribosom
stalk
protein
eeseesdddmgfglfd
fuse
c
terminu
rta
similarli
concept
appli
diphtheria
toxin
chimera
describ
earlier
cleavabl
toxin
pertacleavag
sitestalk
peptid
proteas
minim
cleavag
sequenc
genotyp
junction
insert
rta
ribosom
stalk
peptid
control
uncleav
toxin
pertamut
cleavag
sitestalk
peptid
mutat
cleavag
site
posit
locat
construct
fuse
n
terminu
bind
transloc
domain
pe
natur
bind
transloc
domain
ricin
toxin
rtb
undergo
nglycosyl
produc
ricinu
communi
necessari
lectin
activ
fuse
rta
bacteri
deriv
bind
transloc
domain
pe
chimer
perta
toxin
capabl
penetr
mammalian
cell
cytoplasm
demonstr
previous
pitcher
et
al
may
produc
e
coli
standard
method
enzymat
activ
rtabas
zymoxin
elev
follow
proteas
cleavag
order
assess
suscept
rtazbas
construct
cleavag
evalu
influenc
cleavag
ribosom
depurin
activ
invitro
cleavag
reaction
carri
describ
diphtheria
toxin
chimera
follow
ribosom
depurin
assay
use
acid
anilin
method
ribosom
reticulocyt
lysat
method
phosphodiest
bond
site
depurin
adenin
ricin
treat
rrna
cleav
treatment
anilin
acid
condit
small
fragment
nucleotid
r
fragment
releas
detect
agaros
acrylamid
gel
electrophoresi
stain
ethidium
bromid
schemat
represent
perta
chimer
toxin
invitro
cleavag
ribosom
depurin
assay
result
repres
fig
shown
incub
toxin
pertacleavag
sitestalk
peptid
recombin
proteas
result
complet
cleavag
chimer
toxin
appear
lower
weight
product
fig
upper
panel
contrast
uncleav
toxin
remain
indiffer
presenc
proteas
moreov
cleavag
led
increas
ribosom
depurin
activ
toxin
infer
appear
r
fragment
ribosom
treat
ngml
cleav
toxin
fragment
undetect
ribosom
treat
concentr
noncleav
cleavabl
toxin
cleavabl
toxin
without
incub
uncleav
toxin
fig
higher
toxin
concentr
presenc
anilin
r
fragment
could
detect
treatment
cleav
uncleav
toxin
may
result
fact
zymoxin
partial
total
inhibit
ctermin
extens
also
infer
cytotox
assay
shown
cytotox
rtabas
zymoxin
elev
express
cell
order
verifi
activ
rtabas
toxin
hcv
proteas
invivo
model
cell
line
induc
uninduc
express
treat
pertacleavag
sitestalk
peptid
ribosom
depurin
assay
serial
dilut
toxin
treat
untreat
incub
rabbit
reticulocyt
lysat
minut
total
rna
mixtur
extract
half
rna
treat
acid
anilin
anilin
acet
acid
minut
half
remain
untreat
next
rna
extract
analyz
tbe
agaros
gel
electrophoresi
stain
ethidium
bromid
posit
r
fragment
releas
rrna
ricintr
ribosom
treatment
anilin
mark
arrow
pertamut
cleavag
sitestalk
peptid
shown
fig
tetracyclin
induc
express
full
led
consider
activ
cleavabl
toxin
profound
enhanc
cytotox
control
uncleav
toxin
observ
anoth
construct
extens
fuse
c
terminu
rta
also
rel
inert
proteas
express
exhibit
minor
enhanc
cytotox
toward
tetinduc
express
cell
ic
valu
vs
uninduc
induc
cell
respect
data
shown
elev
cytotox
dta
rta
base
zymoxin
correspond
level
intracellular
proteolyt
activ
elev
cytotox
effect
observ
zymoxin
treat
express
cell
suggest
invivo
depend
activ
zymoxin
thu
direct
correl
level
cellular
proteolyt
activ
enhanc
cytotox
upon
zymoxin
treatment
expect
order
test
assumpt
took
advantag
partial
tunabl
natur
tetracyclin
induc
express
model
cell
line
system
shown
fig
trex
cell
induc
express
full
supplement
two
tetracyclin
concentr
consider
lower
invivo
proteolyt
activ
observ
cell
supplement
lower
tetracyclin
concentr
agreement
less
profound
enhanc
cytotox
observ
low
tetracyclin
concentr
supplement
cell
treat
dta
rta
base
zymoxin
fig
demonstr
expect
posit
correl
cellular
proteolyt
activ
level
enhanc
zymoxin
induc
cytotox
cytotox
dta
rta
base
zymoxin
elev
hepatomaderiv
cell
line
stabli
express
proteas
infect
hcv
order
evalu
potenti
describ
zymoxin
cleav
cytoplasm
hcv
infect
cell
hepatoma
cell
uninfect
infect
chimer
viru
encod
structur
protein
genotyp
strain
within
background
genotyp
strain
transfect
new
set
cleavag
substrat
encod
vector
vector
name
pcmvmbpegfpful
pcmvmbpegfpful
encod
previous
describ
cleavabl
substrat
follow
modif
amino
acid
minim
cleavag
sequenc
genotyp
junction
replac
longer
cleavag
sequenc
amino
acid
aminoacid
strain
genotyp
junction
site
respect
longer
recognit
sequenc
demonstr
cleav
effici
western
blot
analysi
lysat
sampl
uninfect
infect
cell
indic
cleavag
substrat
incorpor
site
infect
cell
proteas
encod
genotyp
compon
chimera
express
fig
left
panel
accordingli
follow
experi
genotyp
deriv
minim
cleavag
site
replac
longer
genotyp
strain
junction
sequenc
dta
rta
base
cleavabl
zymoxin
pedtaful
cleavag
sitedefensin
pertaful
cleavag
sitestalk
peptid
respectivelz
sinc
hcvcc
system
base
hepatoma
cell
line
first
evalu
whether
express
within
cell
would
render
sensit
zymoxin
intox
observ
induc
express
model
cell
line
end
hepatomaderiv
cell
line
stabli
constitut
express
describ
egfpful
genotyp
establish
cell
verifi
invivo
proteolyt
activ
toward
cleavag
substrat
encod
vector
pcmvmbpegfpful
shown
right
panel
fig
substrat
inde
cleav
genotyp
full
proteas
express
cell
next
step
wildtyp
egfpful
express
cell
treat
cleavabl
zymoxin
pedtaful
cleavag
sitedefensin
pertaful
cleavag
sitestalk
peptid
uncleav
control
shown
uncleav
control
toxin
show
enhanc
cytotox
contrast
toxic
cleavabl
zymoxin
enhanc
upon
treatment
full
express
cell
demonstr
express
suffici
sensit
hepatomaderiv
cell
toxin
emphas
potenti
engin
toxin
erad
express
liver
cell
next
turn
evalu
potenti
describ
zymoxin
erad
hcv
infect
cell
seen
fig
treatment
infecteduninfect
cell
cleavabl
dta
rta
base
zymoxin
result
enhanc
cytotox
upon
infect
cell
ic
valu
ngml
dta
base
toxin
toward
uninfect
infect
cell
respect
ngml
rta
base
toxin
toward
uninfect
infect
cell
respect
treatment
uncleav
control
result
much
less
profound
effect
ic
valu
ngml
uncleav
dta
base
toxin
toward
uninfect
infect
cell
respect
ngml
uncleav
rta
base
toxin
toward
uninfect
infect
cell
respect
enhanc
cytotox
upon
infect
cell
observ
follow
treatment
dtabas
uncleav
toxin
pedtano
cleavag
sitedefensin
whole
cleavag
site
delet
data
shown
expect
treatment
infect
cell
toxin
incorpor
cleavag
site
deriv
genotyp
ineffici
cleav
genotyp
encod
proteas
yield
much
reduc
enhanc
cytotox
data
shown
day
vaccin
consid
effici
method
fight
viral
infect
howev
activ
vaccin
gener
taken
prevent
act
usual
patient
still
uninfect
moreov
viral
pathogen
caus
worldwid
health
problem
like
human
immunodefici
viru
hiv
hcv
effici
vaccin
yet
develop
intens
effort
past
decad
focus
discoveri
antivir
agent
interfer
specif
step
viral
life
cycl
includ
viral
entri
rna
translat
posttransl
process
revers
transcript
genom
integr
viral
assembl
releas
process
polyprotein
precursor
viralencod
proteas
essenti
step
life
cycl
mani
virus
partial
list
human
diseas
associ
virus
encod
proteas
genom
includ
flavivirus
hepat
c
viru
hcv
west
nile
viru
wnv
dengu
fever
viru
dfv
yellow
fever
viru
yfv
retrovirus
picornavirus
coxsackieviru
polioviru
hepat
viru
nidovirus
coronavirus
cov
includ
sever
acut
respiratori
syndrom
sar
caus
sarscov
herpesvirus
varicellazost
viru
vzv
epsteinbar
viru
ebv
conceiv
mani
virus
list
target
zymoxin
approach
depend
intracellular
locat
expressionact
level
encod
proteas
varshavski
suggest
innov
concept
antivir
therapi
base
idea
take
advantag
specif
viral
activ
instead
inhibit
propos
antivir
agent
denot
sitoxin
signalregul
cleavagemedi
toxin
artifici
compos
intracellular
signal
moieti
inactiv
toxin
eg
degrad
signal
cleav
viral
proteas
result
select
intox
viral
infect
cell
later
studi
slightli
differ
strategi
construct
viralproteas
activ
agent
also
appli
strategi
base
zymogen
potenti
toxic
enzym
name
convert
constitut
activ
enzym
proteaseactivat
form
way
mediat
intracellular
signal
moieti
zymogen
agent
present
three
eleg
studi
plasmodium
falciparum
hiv
hcv
proteas
activ
zymogen
design
circular
permut
bovin
rnase
enzym
modifi
expos
nativ
structur
activ
site
upon
proteolyt
cleavag
specif
mediat
proteas
elicit
profound
enhanc
invitro
rnase
activ
anoth
studi
carri
jucov
colleagu
random
propeptid
librari
fuse
ctermin
end
actin
modifi
veget
insecticid
protein
vip
produc
sporeform
bacterium
bacillu
cereu
select
malfunct
fusion
variant
yeast
identifi
proenzym
significantli
reduc
enzymat
activ
abil
express
transgen
corn
plant
without
caus
development
patholog
moreov
engin
zymogen
still
power
enough
caus
mortal
western
corn
rootworm
larva
major
pest
corn
unit
state
due
proteolyt
activ
rootworm
digest
system
recent
law
et
al
demonstr
convers
natur
zymogen
maiz
ribosom
inactiv
protein
maiz
rip
hiv
proteaseactiv
toxin
maiz
rip
type
iii
ribosomeinactiv
protein
nativ
form
synthes
inact
precursor
prorip
activ
proteolyt
remov
aminoacid
inhibitori
intern
peptid
inplanta
replac
first
last
residu
intern
inactiv
region
two
hivproteas
recognit
sequenc
modifi
zymogen
toxin
prepar
show
enhanc
enzymat
antivir
activ
demonstr
sever
rip
possess
potent
antivir
activ
hiv
infect
cell
howev
data
relat
differ
cytotox
uninfect
vs
infect
cell
provid
thu
potenc
reengin
toxin
actual
erad
hiv
infect
cell
determin
treat
retrovir
infect
erad
infect
cell
import
ad
valu
inhibit
viral
replic
particl
product
live
cell
reason
infect
cell
may
contain
integr
provir
dna
genom
elimin
destroy
cell
zymoxin
studi
describ
herein
tri
similar
approach
order
convert
maiz
rip
hcv
proteaseactiv
toxin
howev
hand
insert
replac
sequenc
surround
intern
inhibitori
peptid
cleavabl
sequenc
gener
toxin
exhibit
signific
enhanc
cytotox
express
cell
unpublish
data
integr
concept
sitoxin
strategi
enzym
zymogen
develop
two
ration
design
viralproteas
activ
chimer
toxin
denot
zymoxin
zymogen
toxin
hcv
proteas
chosen
serv
model
viral
encod
proteas
express
activ
infect
cell
essenti
viral
replicationmatur
zymoxin
bind
transloc
domain
pseudomona
exotoxin
pe
use
vehicl
deliveri
cleavabl
zymogen
catalyt
subunit
diphtheria
toxin
corynebacterium
diphtheria
ricin
ricinu
communi
cytosol
mammalian
cell
contrast
sitoxin
inhibitori
activ
mediat
intracellular
compon
recogn
cleavabl
signal
polypeptid
fuse
toxin
inhibit
toxic
activ
zymoxin
mediat
sole
modif
appli
origin
toxin
therefor
first
confirm
proteolyt
activ
two
zymoxin
invitro
activ
assay
order
assay
transloc
capabl
proteolyt
activ
invivo
model
cell
line
induc
express
hcv
establish
previous
report
sitoxin
preactiv
invitro
hiv
proteas
increas
abil
inhibit
cellular
protein
synthesi
howev
sitoxin
subsequ
fail
inhibit
growth
hiv
infect
cell
suggest
author
failur
due
fact
hiv
virusencod
proteas
locat
plasma
membran
avail
activ
sitoxin
henc
zymoxin
activ
assay
use
cytosol
membraneassoci
express
cell
cellular
local
proteas
may
influenc
probabl
interact
transloc
toxin
latter
model
membran
associ
express
system
particularli
import
sinc
precis
mimic
intracellular
local
genuin
viralencod
proteas
domain
result
show
consider
enhanc
cytotox
two
zymoxin
model
cell
line
lead
specif
erad
proteas
express
cell
specif
rang
zymoxin
concentr
demonstr
compet
bind
transloc
domain
pe
mediat
deliveri
dta
rta
catalyt
domain
cell
cytoplasm
importantli
cleavag
mediat
enhanc
enzymat
activ
two
zymoxin
detect
invitro
assay
practic
translat
enhanc
cytotox
activ
order
test
compet
zymoxin
erad
hcv
infect
liver
cell
util
one
current
use
model
studi
hepat
c
viru
recombin
infecti
hcv
particl
produc
cell
cultur
hcvcc
base
hepatoma
cell
line
first
verifi
express
sensit
liver
cell
zymoxin
intox
observ
follow
induc
express
cell
line
final
show
treatment
cleavabl
dta
rta
base
zymoxin
result
enhanc
cytotox
toward
hcv
infect
cell
contrast
cell
treat
uncleav
control
toxin
therapeut
window
observ
support
authent
result
provid
unpublish
observ
toxin
incorpor
genotyp
deriv
hcv
site
ineffici
cleav
genotyp
encod
proteas
hcv
infect
cell
result
minor
undetect
enhanc
cytotox
upon
treatment
infect
cell
note
experi
hcv
infect
cell
therapeut
window
fold
narrow
observ
case
induc
express
trex
cell
line
condit
full
induct
valu
also
smaller
observ
similar
experi
express
cell
therapeut
window
fold
record
appar
level
proteas
activ
hcv
infect
cell
lower
level
model
cell
line
also
evid
compar
left
right
panel
fig
conclus
design
two
antivir
agent
present
work
inspir
sitoxin
concept
present
varshavski
recent
work
field
enzym
engin
abil
agent
activ
viral
proteas
provid
proof
concept
feasibl
zymogen
natur
toxin
ration
design
relay
previou
knowledg
toxin
structur
interact
substrat
exist
peptid
inhibitor
although
practic
use
may
requir
research
develop
order
broaden
therapeut
window
reduc
potenti
immunogen
drug
erad
viral
infect
cell
use
zymogen
toxin
may
repres
anoth
strategi
fight
viral
diseas
still
zymoxin
approach
may
appropri
applic
lifethreaten
acut
infect
much
higher
level
activ
proteas
one
observ
hcv
infect
cell
would
expect
follow
escherichia
coli
strain
use
blue
stratagen
usa
plasmid
propag
rosetta
novagen
usa
express
promoterdriven
recombin
toxin
recombin
dna
techniqu
carri
accord
standard
protocol
recommend
supplier
nucleotid
sequenc
determin
use
prism
genet
analyz
appli
biosystem
usa
accord
supplier
recommend
bacteri
promoterbas
express
vector
use
express
recombin
toxin
escherichia
coli
novagen
usa
eukaryot
tetracyclineinduc
cmv
promoterbas
express
vector
pcdna
use
express
egfpful
trex
cell
line
invitrogen
usa
plasmid
dna
fragment
purif
carri
hiyield
plasmid
mini
kit
hiyield
gelpcr
dna
extract
kit
rbc
bioscienc
taiwan
dna
ligas
restrict
enzym
purchas
new
england
biolab
usa
dna
ligat
carri
overnight
genom
dna
extract
ricinu
communi
perform
describ
construct
tetracyclineinduc
vector
encod
previous
describ
singlechain
code
sequenc
amplifi
pcr
use
plasmid
dna
templat
primer
primer
sequenc
given
support
tabl
pcr
product
digest
hindiii
apai
restrict
site
underlin
primer
sequenc
clone
correspond
site
clontech
usa
gener
plasmid
pegfp
next
fragment
contain
code
sequenc
fusion
excis
plasmid
digest
iii
apai
clone
correspond
site
tetracyclin
induc
vector
pcdna
gener
plasmid
pcdna
construct
tetracyclineinduc
vector
encod
egfpful
code
sequenc
full
length
includ
helicas
domain
follow
hcv
genotyp
excis
plasmid
kindli
provid
prof
matti
llberg
karolinska
univers
hospit
sweden
digest
nari
apai
dna
fragment
clone
correspond
site
pcdna
replac
sequenc
gener
plasmid
pcdna
egfpful
construct
vector
encod
pedtacleavag
sitedefensin
zymoxin
shown
schemat
fig
code
sequenc
amino
acid
pseudomona
exotoxin
pe
includ
signal
peptid
amplifi
pcr
plasmid
encod
pe
deriv
peqq
delta
kindli
provid
dr
ira
pastan
nci
nih
bethesda
md
usa
lysin
substitut
glutamin
residu
lysin
delet
amplif
process
dna
sequenc
encod
amino
acid
minim
cleavag
sequenc
hcv
site
deriv
hcv
genotyp
follow
mfei
site
psti
site
histidin
residu
kdel
er
retriev
signal
introduc
end
toxin
code
sequenc
primer
use
forward
primer
revers
primer
order
pcr
product
forward
first
revers
primer
use
templat
reaction
forward
second
revers
primer
final
pcr
product
digest
xbai
ecori
clone
correspond
site
bacteri
express
plasmid
gener
plasmid
pe
qq
delta
next
human
alphadefensin
code
sequenc
preced
flexibl
linker
amino
acid
follow
linker
amino
acid
rich
glycin
serin
insert
plasmid
insert
creat
pcr
use
plasmid
pe
qq
delta
dna
templat
revers
primer
forward
primer
order
pcr
product
revers
first
forward
primer
use
templat
reaction
revers
second
forward
primer
pcr
product
digest
psti
ecori
clone
correspond
site
plasmid
use
templat
gener
plasmid
pe
qq
delta
linkerhnphiskdel
next
step
dna
fragment
encod
diphtheria
toxin
kindli
provid
prof
nadir
arber
integr
cancer
prevent
center
tel
aviv
souraski
medic
center
israel
use
templat
pcr
amplif
region
encod
amino
acid
matur
toxic
domain
without
signal
peptid
amplif
process
dna
sequenc
encod
deriv
junction
introduc
end
toxin
code
sequenc
primer
use
pcr
product
digest
restrict
enzym
aatii
mfei
clone
correspond
site
plasmid
pe
qq
delta
linkerhnphiskdel
gener
plasmid
pe
qq
delta
dta
instead
domain
iii
linkerhnphiskdel
catalyt
domain
pe
domain
iii
replac
amino
acid
dta
follow
cleavabl
junction
sequenc
flexibl
linker
amino
acid
rich
glycin
serin
human
alphadefensin
code
sequenc
short
amino
acid
linker
kdel
retriev
signal
protein
sequenc
zymoxin
describ
well
zymoxin
use
studi
found
support
text
construct
vector
encod
rta
base
cleavabl
zymoxin
pertacleavag
sitestalk
peptid
shown
schemat
fig
code
sequenc
catalyt
domain
ricin
toxin
chain
amino
acid
amplifi
ricinu
communi
genom
dna
prepar
pcr
use
primer
pcr
product
digest
sacii
mfei
clone
correspond
site
plasmid
pe
qq
delta
gener
plasmid
pe
qq
delta
iiiibrta
hiskdel
serv
templat
anoth
pcr
use
forward
primer
revers
primer
pcr
product
digest
sacii
psti
clone
correspond
site
plasmid
use
templat
gener
plasmid
pe
qq
delta
linkerstalk
peptidehiskdel
two
repeat
acid
residu
peptid
correspond
conserv
c
terminu
ribosom
stalk
protein
eeseesdddmgfglfd
fuse
c
terminu
rta
preced
cleavabl
junction
sequenc
deriv
genotyp
short
linker
glyglyglyglys
follow
kdel
er
retriev
signal
construct
vector
encod
uncleav
control
zymoxin
pertamut
cleavag
sitestalk
peptid
shown
schemat
fig
minim
cleavag
sequenc
deriv
junction
hcv
genotyp
plasmid
pe
qq
delta
linkerstalk
peptidehiskdel
mutat
substitut
cystein
arginin
tyrosin
alanin
use
dna
plasmid
pe
qq
delta
linkerstalk
peptidehiskdel
templat
primer
pcr
product
digest
bamhi
ecori
clone
correspond
site
plasmid
use
templat
gener
plasmid
pe
qq
delta
rtamut
linkerstalk
peptidehiskdel
construct
vector
encod
pertacleavag
sitestalk
peptid
zymoxin
cleavag
sequenc
deriv
genotyp
junction
replac
cleavag
sequenc
deriv
genotyp
strain
junction
pertaful
cleavag
sitestalk
peptid
pcr
carri
use
dna
plasmid
pe
qq
delta
linkerstalk
peptidehiskdel
templat
revers
primer
forward
primer
pcr
product
digest
bamhi
xhoi
clone
correspond
site
plasmid
templat
gener
plasmid
pe
qq
delta
rtaful
linkerstalk
peptidehiskdel
construct
vector
encod
cleavabl
substrat
bear
cleavag
sequenc
deriv
genotyp
junction
shown
schemat
fig
code
sequenc
excis
plasmid
digest
ncoi
bamhi
ligat
correspond
site
plasmid
pcmv
gener
plasmid
construct
vector
encod
cleavabl
substrat
mbpegfpful
bear
cleavag
sequenc
deriv
genotyp
junction
pcr
carri
use
dna
plasmid
templat
revers
primer
forward
primer
pcr
product
digest
nhei
hindiii
clone
correspond
site
plasmid
use
templat
gener
plasmid
pcmvmbpegfpful
construct
vector
encod
cleavabl
substrat
mbpegfpful
bear
cleavag
sequenc
deriv
genotyp
strain
junction
pcr
carri
use
dna
plasmid
templat
revers
primer
forward
primer
pcr
product
digest
nhei
hindiii
clone
correspond
site
plasmid
use
templat
gener
plasmid
pcmvmbpegfpful
e
coli
rosetta
cell
transform
base
express
plasmid
grown
liter
lb
medium
supplement
mgml
kanamycin
rpm
shake
cell
chill
induc
iptg
hour
rpm
cell
collect
centrifug
minut
prepar
periplasm
fraction
cell
pellet
gentli
resuspend
ml
icecold
sucros
trishcl
ph
edta
use
glass
bead
cell
suspens
incub
ice
minut
centrifug
minut
cell
pellet
gentli
resuspend
ml
ice
cold
steril
doubl
distil
water
ddw
incub
ice
minut
centrifug
minut
supernat
periplasm
fraction
adjust
trishcl
ph
nacl
imidazol
periplasm
fraction
incub
overnight
continu
rotat
ninta
resin
favorgen
taiwan
previous
equilibr
bind
buffer
trishcl
ph
nacl
ninta
resin
separ
periplasm
supernat
minut
centrifug
load
poli
prep
column
biorad
usa
wash
bind
buffer
imidazol
bound
histag
protein
subsequ
elut
pb
contain
imidazol
dialyz
twice
liter
pb
human
embryon
kidney
cell
stabli
express
tetracyclin
repressor
protein
trex
cell
line
invitrogen
usa
human
hepatoma
cell
use
throughout
studi
cell
line
maintain
dmem
supplement
fetal
calf
serum
fc
mm
lglutamin
uml
penicillin
mgml
streptomycin
uml
nystatin
biolog
industri
israel
humidifi
co
incub
calciumphosph
transfect
method
appli
introduc
plasmid
pcdna
pcdna
egfpful
trex
cell
seed
cell
per
plate
hour
transfect
stabl
transfect
induc
express
egfpful
select
medium
contain
zeocin
select
mainten
respect
cayla
franc
plasmid
pcmv
mbpegfpful
pcmv
mbpegfpful
pcdna
egfpful
introduc
uninfect
hcv
infect
cell
seed
cell
per
well
plate
hour
transfect
use
fugen
reagent
roch
germani
accord
manufactur
instruct
stabl
transfect
constitut
express
egfpful
select
maintain
medium
contain
zeocin
select
mainten
respect
protein
extract
hour
posttransfect
cell
wash
pb
scrape
lyse
buffer
contain
mm
nacl
mm
edta
mm
tri
hcl
ph
proteas
inhibitor
cocktail
sigma
israel
follow
minut
incub
ice
lysat
clear
centrifug
g
minut
immunoblot
protein
sampl
electrophores
sd
polyacrylamid
gel
transfer
nitrocellulos
detect
use
rabbit
polyclon
antigfp
antibodi
santacruz
usa
polyclon
mous
serum
antimbp
follow
hrpconjug
goat
antirabbit
antimous
mous
antibodi
jackson
immunoresearch
laboratori
usa
ecl
detect
immunoblot
purifi
recombin
toxin
similarli
perform
use
rabbit
polyclon
antip
antibodi
kindli
provid
dr
ira
pastan
nci
nih
bethesda
md
usa
viru
assay
carri
intergenotyp
chimer
viru
produc
replac
segment
viru
genom
compar
segment
genotyp
viru
chimer
viru
kindli
provid
prof
stanley
lemon
univers
texa
galveston
contain
two
compensatori
mutat
promot
growth
cell
cultur
describ
previous
hcv
rna
transcrib
vitro
electropor
cell
essenti
describ
previous
brief
mg
vitrosynthes
hcv
rna
mix
cell
cuvett
puls
twice
kv
mf
cell
seed
plate
flask
passag
interv
posttransfect
trypsin
reseed
split
fresh
cultur
vessel
infect
reach
monitor
immunofluoresc
stain
anti
hcv
core
protein
cell
taken
cytotox
substrat
cleavag
assay
immunofluoresc
microscopi
trex
cell
induc
express
egfpful
seed
polyllysin
coat
coverslip
wellplat
hour
cell
treat
ml
tetracyclin
hour
remain
untreat
wash
pb
fix
paraformaldehyd
pb
room
temperatur
minut
permeabil
triton
pb
minut
block
fetal
calf
pb
room
temperatur
minut
slide
incub
dilut
rabbitpolyclon
anticalnexin
antibodi
sigma
usa
primari
antibodi
hour
follow
dilut
antirabbit
igg
jackson
immunoresearch
laboratori
usa
secondari
antibodi
hoechst
sigma
usa
hour
room
temperatur
slide
wash
pb
mount
immuglo
mount
medium
immco
diagnost
usa
examin
zeiss
lsm
meta
laser
scan
confoc
microscop
infect
assay
cell
infect
hcv
chimer
viru
seed
chamber
slide
nalg
nunc
usa
hour
cell
fix
permeabil
describ
stain
dilut
mous
monoclon
antibodi
affin
bioreag
usa
specif
hcv
core
protein
follow
stain
dilut
goat
antimous
igg
jackson
immunoresearch
laboratori
usa
slide
mount
examin
use
fluoresc
microscop
invitro
cleavag
dta
rta
base
toxin
dta
base
toxin
rta
base
toxin
incub
without
respect
recombin
fusion
reaction
buffer
trishcl
ph
nacl
tween
glycerol
dtt
total
volum
hour
mediat
cleavag
verifi
western
blot
dta
base
toxin
rta
base
toxin
toxin
sampl
use
rabbit
polyclon
antip
antibodi
describ
adpribosyl
activ
dta
base
toxin
determin
measur
transfer
adpribos
c
nad
essenti
describ
shortli
toxin
dilut
trishcl
ph
mm
edta
bsa
mixtur
incub
wheat
germ
extract
presenc
mm
c
nad
cpm
amersham
bioscienc
uk
minut
rt
reaction
termin
addit
tca
reaction
mixtur
result
total
protein
precipit
level
adpribosyl
assess
measur
radioact
precipit
protein
scintil
counter
catalyt
activ
ricin
base
toxin
determin
modif
invitro
assay
describ
serial
dilut
cleavabl
uncleav
rta
base
toxin
treat
untreat
incub
micrococc
nucleasetr
rabbit
reticulocyt
lysat
promega
usa
minut
total
rna
mixtur
extract
phenol
chloroform
precipit
ethanol
suspend
water
half
rna
treat
acid
anilin
anilin
acet
acid
minut
half
remain
untreat
next
rna
recov
precipit
ammonium
acet
ethanol
analyz
tbe
agaros
gel
electrophoresi
cellkil
activ
recombin
toxin
measur
mtt
assay
cytotox
assay
trex
cell
induc
express
proteas
cell
seed
per
well
plate
hour
respect
cell
treat
indic
concentr
tetracyclin
left
untreat
hour
later
respect
cell
incub
serial
dilut
toxin
presenc
tetracyclin
kept
growth
media
induc
cell
hour
media
replac
fresh
media
ml
per
well
contain
mgml
mtt
thiazolyl
blue
tetrazoliam
bromid
sigma
usa
dissolv
pb
reagent
cell
incub
anoth
minut
mttformazan
crystal
dissolv
addit
extract
solut
sd
dmf
ph
ml
per
well
incub
hour
absorb
nm
record
autom
microtit
plate
reader
result
express
percentag
live
cell
rel
untreat
control
ic
valu
concentr
toxin
inhibit
cell
growth
cytotox
assay
hcv
infect
uninfect
cell
express
cell
cell
uninfect
infect
chimer
viru
stabli
express
proteas
seed
per
well
plate
hour
cell
incub
serial
dilut
toxin
hour
later
media
replac
fresh
media
ml
per
well
contain
mgml
mtt
cell
incub
anoth
minut
step
ident
these
describ
tabl
oligonucleotid
primer
use
studi
doc
text
protein
sequenc
cleavabl
uncleav
zymoxin
use
studi
doc
